Literature DB >> 3000147

Immune responses of cattle and mice to the G glycoprotein of vesicular stomatitis virus.

T Yilma, R G Breeze, S Ristow, J R Gorham, S R Leib.   

Abstract

A subunit vaccine for vesicular stomatitis was developed from a purified vesicular stomatitis virus preparation by selectively removing the immunogenic G glycoprotein of the virus with the dialyzable, nonionic detergent, beta-D-octylglucoside. Cattle immunized intramuscularly with a single dose of 112 micrograms of G glycoprotein preparation in complete Freund's adjuvant did not develop vesicular disease following challenge by intralingual inoculation of 400 times the infectious dose of the virus. Similarly, mice vaccinated subcutaneously with a single dose of 10 micrograms of G glycoprotein preparation, with or without complete Freund's adjuvant, were protected from lethal encephalitis caused by vesicular stomatitis virus. A subunit vaccine for vesicular stomatitis of cattle, horses, and swine avoids the hazards associated with attenuated and inactivated vaccines, such as vaccine breaks, reversion to virulence, or introduction of virus into potential wild reservoirs or arthropod hosts. Further, it is possible to distinguish serologically animals vaccinated with the subunit preparation from those that have had the clinical disease or that have been vaccinated with whole virus. This is an essential consideration both for epidemiological studies and for disease control or establishment of quarantine programs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000147     DOI: 10.1007/978-1-4684-7974-4_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo.

Authors:  Fatema A Legrand; Paulo H Verardi; Kenneth S Chan; Yue Peng; Leslie A Jones; Tilahun D Yilma
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-10       Impact factor: 11.205

2.  Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development.

Authors:  E B Flanagan; J M Zamparo; L A Ball; L L Rodriguez; G W Wertz
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity.

Authors:  P H Verardi; L A Jones; F H Aziz; S Ahmad; T D Yilma
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.

Authors:  Fatema A Legrand; Paulo H Verardi; Leslie A Jones; Kenneth S Chan; Yue Peng; Tilahun D Yilma
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic.

Authors:  Paulo H Verardi; Fatema A Legrand; Kenneth S Chan; Yue Peng; Leslie A Jones; Tilahun D Yilma
Journal:  J Interferon Cytokine Res       Date:  2013-10-29       Impact factor: 2.607

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.